The developing female genital tract: From genetics to epigenetics

International Journal of Developmental Biology

Volumn 53, Issue 2-3, 2009, Pages 411-424

  Massé, Julie ^a   Watrin, Tanguy ^a   Laurent, Audrey ^a   Deschamps, Stéphane ^a   Guerrier, Daniel ^a   Pellerin, Isabelle ^a  

^a UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Epigenetics; Genetics; Genital tract; Hox; Wnt

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; DNA; ENDOCRINE DISRUPTOR; ESTROGEN; GENISTEIN; GENOMIC DNA; HOX PROTEIN; TRANSCRIPTION FACTOR EMX2; TRANSCRIPTION FACTOR MSX2; TRANSCRIPTION FACTOR PAX2; WNT PROTEIN; SEX HORMONE;

DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; FEMALE GENITAL SYSTEM DEVELOPMENT; GENE FUNCTION; GENETIC ANALYSIS; GONAD DEVELOPMENT; HORMONE ACTION; HUMAN; MOLECULAR GENETICS; MOLECULAR MECHANICS; MUELLERIAN DUCT; NONHUMAN; ORGANOGENESIS; OVARY DEVELOPMENT; PENETRANCE; PRIORITY JOURNAL; REVIEW; URINARY TRACT; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; FEMALE; FEMALE GENITAL SYSTEM; FETUS DEVELOPMENT; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PHYSIOLOGY; PRENATAL DEVELOPMENT;

MAMMALIA;

ANIMALS; EPIGENESIS, GENETIC; FEMALE; FETAL DEVELOPMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENITALIA, FEMALE; GONADAL STEROID HORMONES; HUMANS; MODELS, BIOLOGICAL; MULLERIAN DUCTS;

EID: 70349335527     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.082680jm     Document Type: Review

References (142)

1. AAMAR, E. and FRANK D. (2004). Xenopus Meis3 protein forms a hindbraininducing center by activating FGF/MAP kinase and PCP pathways. Development 131: 153-163.
2. ALLARD, S., ADIN P., GOUEDARD L., DI CLEMENTE N., JOSSO N., ORGEBINCRIST M.C., PICARD J.Y. and XAVIER F. (2000). Molecular mechanisms of hormone-mediated Mullerian duct regression: involvement of beta-catenin. Development 127: 3349-3360.
3. ANWAY, M.D., CUPP A.S., UZUMCU M. and SKINNER M.K. (2005). Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308: 1466-1469.
4. ARANGO, N.A., SZOTEK P.P., MANGANARO T.F., OLIVA E., DONAHOE P.K. and TEIXEIRA J. (2005). Conditional deletion of beta-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol 288: 276-283.
5. BALFOUR, F.M., SEDGEWICK,A. (1879). On the existence of a head-kidney in the embryo chick, and on certain points in the development of Müllerian duct. K.J.Microsc. Sci. 19: 1-19.
6. BASILE, C. and DE MICHELE V. (2001a). Renal abnormalities in Mayer-Rokitanski-Kuster-Hauser syndrome. J Nephrol 14: 316-318.
7. BASILE, C. and DE MICHELE V. (2001b). Renal abnormalities in Mayer-Rokitanski-Kuster-Hauser syndrome. J Nephrol. 14: 316-318.
8. BEHRINGER, R.R., FINEGOLD M.J. and CATE R.L. (1994). Mullerian-inhibiting substance function during mammalian sexual development. Cell 79: 415-425.
9. BENSON, G.V., LIM H., PARIA B.C., SATOKATA I., DEY S.K. and MAAS R.L. (1996). Mechanisms of reduced fertility in Hoxa-10 mutant mice: uterine homeosis and loss of maternal Hoxa-10 expression. Development 122: 2687-2696.
10. BIASON-LAUBER, A., KONRAD D., NAVRATIL F. and SCHOENLE E.J. (2004). A WNT4 mutation associated with Mullerian-duct regression and virilization in a 46,XX woman. N Engl J Med 351: 792-798.
11. BINGHAM, C., BULMAN M.P., ELLARD S., ALLEN L.I., LIPKIN G.W., HOFF W.G., WOOLF A.S., RIZZONI G., NOVELLI G., NICHOLLS A.J. and HATTERSLEY A.T. (2001). Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease. Am J Hum Genet 68: 219-224.
12. BINGHAM, C., ELLARD S., COLE T.R., JONES K.E., ALLEN L.I., GOODSHIP J.A., GOODSHIP T.H., BAKALINOVA-PUGH D., RUSSELL G.I., WOOLF A.S., NICHOLLS A.J. and HATTERSLEY A.T. (2002). Solitary functioning kidney and diverse genital tract malformations associated with hepatocyte nuclear factor-1beta mutations. Kidney Int 61: 1243-1251.
13. BLATT, J., VAN LE L., WEINER T. and SAILER S. (2003). Ovarian carcinoma in an adolescent with transgenerational exposure to diethylstilbestrol. J Pediatr Hematol Oncol 25: 635-636.
14. BLOCK, K., KARDANA A., IGARASHI P. and TAYLOR H.S. (2000). In utero diethylstilbestrol (DES) exposure alters Hox gene expression in the developing mullerian system. FASEB J 14: 1101-1108.
15. BONDOS, S. (2006). Variations on a theme: Hox and Wnt combinatorial regulation during animal development. Sci STKE 2006: pe38.
16. BOUCHARD, M., SOUABNI A., MANDLER M., NEUBUSER A. and BUSSLINGER M. (2002). Nephric lineage specification by Pax2 and Pax8. Genes Dev 16: 2958-7290.
17. BRANHAM, W.S., SHEEHAN D.M., ZEHR D.R., RIDLON E. and NELSON C.J. (1985). The postnatal ontogeny of rat uterine glands and age-related effects of 17 beta-estradiol. Endocrinology 117: 2229-2237.
18. BRODY, J.R. and CUNHA G.R. (1989). Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: I. Normal development. Am J Anat 186: 1-20.
19. CARROLL, T.J., PARK J.S., HAYASHI S., MAJUMDAR A. and MCMAHON A.P. (2005). Wnt9b plays a central role in the regulation of mesenchymal to epithelial transitions underlying organogenesis of the mammalian urogenital system. Dev Cell 9: 283-292.
20. CARTA, L. and SASSOON D. (2004). Wnt7a is a suppressor of cell death in the female reproductive tract and is required for postnatal and estrogen-mediated growth. Biol Reprod 71: 444-454.
21. CISNEROS, F.J. (2004). DNA methylation and male infertility. Front Biosci 9: 1189-1200.
22. CLARKE, T.R., HOSHIYA Y., YI S.E., LIU X., LYONS K.M. and DONAHOE P.K. (2001). Mullerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression. Mol Endocrinol 15: 946-959.
23. COFFINIER, C., BARRA J., BABINET C. and YANIV M. (1999). Expression of the vHNF1/HNF1beta homeoprotein gene during mouse organogenesis. Mech Dev 89: 211-213.
24. COLBORN, T., VOM SAAL F.S. and SOTO A.M. (1993). Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101: 378-384.
25. COUSE, J.F., DIXON D., YATES M., MOORE A.B., MA L., MAAS R. and KORACH K.S. (2001). Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract. Dev Biol 238: 224-238.
26. COUSE, J.F. and KORACH K.S. (1999). Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 20: 358-417.
27. COUSE, J.F. and KORACH K.S. (2004). Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract. Toxicology 205: 55-63.
28. COX, S., SMITH L., BOGANI D., CHEESEMAN M., SIGGERS P. and GREENFIELD A. (2006). Sexually dimorphic expression of secreted frizzled-related (SFRP) genes in the developing mouse Mullerian duct. Mol Reprod Dev 73: 1008-1016.
29. CROPLEY, J.E., SUTER C.M., BECKMAN K.B. and MARTIN D.I. (2006). Germ-line epigenetic modification of the murine A vy allele by nutritional supplementation. Proc Natl Acad Sci USA 103: 17308-17312.
30. CROPLEY, J.E., SUTER C.M. and MARTIN D.I. (2007). Methyl donors change the germline epigenetic state of the A (vy) allele. FASEB J 21: 3021; author reply 3021-302.
31. CUNHA, G.R. (1975). The dual origin of vaginal epithelium. Am J Anat 143: 387-392.
32. CUNHA, G.R. (1976a). Epithelial-stromal interactions in development of the urogenital tract. Int Rev Cytol 47: 137-194.
33. CUNHA, G.R. (1976b). Stromal induction and specification of morphogenesis and cytodifferentiation of the epithelia of the Mullerian ducts and urogenital sinus during development of the uterus and vagina in mice. J Exp Zool 196: 361-370.
34. CUNHA, G.R., BATTLE E., YOUNG P., BRODY J., DONJACOUR A., HAYASHI N. and KINBARA H. (1992). Role of epithelial-mesenchymal interactions in the differentiation and spatial organization of visceral smooth muscle. Epithelial Cell Biol 1: 76-83.
35. CUNHA, G.R., YOUNG P. and BRODY J.R. (1989). Role of uterine epithelium in the development of myometrial smooth muscle cells. Biol Reprod 40: 861-871.
36. DAFTARY, G.S. and TAYLOR H.S. (2006). Endocrine regulation of HOX genes. Endocr Rev 27: 331-355.
37. DAVIS, R.J., HARDING M., MOAYEDI Y. and MARDON G. (2008). Mouse Dach1 and Dach2 are redundantly required for Mullerian duct development. Genesis 46: 205-213.
38. DEUTSCHER, E. and HUNG-CHANG YAO H. (2007). Essential roles of mesenchyme-derived beta-catenin in mouse Mullerian duct morphogenesis. Dev Biol 307: 227-236.
39. CLEMENTE, N. and BELVILLE C. (2006). Anti-Mullerian hormone receptor defect. Best Pract Res Clin Endocrinol Metab 20: 599-610.
40. DIECKMANN, W.J., DAVIS M.E., RYNKIEWICZ L.M. and POTTINGER R.E. (1953). Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 66: 1062-1081.
41. DOHR, G., TARMANN T. and SCHIECHL H. (1987a). Different antigen expression on Wolffian and Mullerian cells in rat embryos as detected by monoclonal antibodies. Anat Embryol (Berl) 176: 239-242.
42. DOHR, G., TARMANN T. and SCHIECHL H. (1987b). Different antigen expression on Wolffian and Mullerian cells in rat embryos as detected by monoclonal antibodies. Anat Embryol (Berl). 176: 239-242.
43. DOLLE, P., DIERICH A., LEMEUR M., SCHIMMANG T., SCHUHBAUR B., CHAMBON P. and DUBOULE D. (1993). Disruption of the Hoxd-13 gene induces localized heterochrony leading to mice with neotenic limbs. Cell 75: 431-441.
44. DOLLE, P., IZPISUA-BELMONTE J.C., BROWN J.M., TICKLE C. and DUBOULE D. (1991). HOX-4 genes and the morphogenesis of mammalian genitalia. Genes Dev 5: 1767-7.
45. DREWS, U., SULAK O. and SCHENCK P.A. (2002). Androgens and the development of the vagina. Biol Reprod 67: 1353-1359.
46. DREYER, C. and ELLINGER-ZIEGELBAUER H. (1996). Retinoic acid receptors and nuclear orphan receptors in the development of Xenopus laevis. Int J Dev Biol. 40: 255-262.
47. FRAGA, M.F., BALLESTAR E., PAZ M.F., ROPERO S., SETIEN F., BALLESTAR M.L., HEINE-SUNER D., CIGUDOSA J.C., URIOSTE M., BENITEZ J., BOIXCHORNET M., SANCHEZ-AGUILERA A., LING C., CARLSSON E., POULSEN P., VAAG A., STEPHAN Z., SPECTOR T.D., WU Y.Z., PLASS C. and ESTELLER M. (2005). Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 102: 10604-10609.
48. FUJINO, A., ARANGO N.A., ZHAN Y., MANGANARO T.F., LI X., MAC LAUGHLIN D.T. and DONAHOE P.K. (2009). Cell migration and activated PI3K/AKTdirected elongation in the developing rat Müllerian duct. Dev Biol 325: 351-362.
49. GENDRON, R.L., PARADIS H., HSIEH-LI H.M., LEE D.W., POTTER S.S. and MARKOFF E. (1997). Abnormal uterine stromal and glandular function associated with maternal reproductive defects in Hoxa-11 null mice. Biol Reprod 56: 1097-1105.
50. GOODMAN, F.R., BACCHELLI C., BRADY A.F., BRUETON L.A., FRYNS J.P., MORTLOCK D.P., INNIS J.W., HOLMES L.B., DONNENFELD A.E., FEINGOLD M., BEEMER F.A., HENNEKAM R.C. and SCAMBLER P.J. (2000). Novel HOXA13 mutations and the phenotypic spectrum of hand-foot-genital syndrome. Am J Hum Genet 67: 197-202.
51. GRAY, C.A., BARTOL F.F., TARLETON B.J., WILEY A.A., JOHNSON G.A., BAZER F.W. and SPENCER T.E. (2001). Developmental biology of uterine glands. Biol Reprod 65: 1311-1323.
52. GROOTHUIS, P.G., DASSEN H.H., ROMANO A. and PUNYADEERA C. (2007). Estrogen and the endometrium: lessons learned from gene expression profiling in rodents and human. Hum Reprod Update 13: 405-417.
53. GRUENWALD, P. (1941). The relation of the growing Mullerian duct to the Wolffian duct and its importance for the genesis of malformations. Anat. Rec. 81: 1-19.
54. GRUN, F. and BLUMBERG B. (2006). Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147: S50-S55.
55. GUIOLI, S., SEKIDO R. and LOVELL-BADGE R. (2007). The origin of the Mullerian duct in chick and mouse. Dev Biol 302: 389-398.
56. HANNEMA, S.E. and HUGHES I.A. (2007). Regulation of Wolffian duct development. Horm Res 67: 142-151.
57. HEIKKILA, M., PRUNSKAITE R., NAILLAT F., ITARANTA P., VUORISTO J., LEPPALUOTO J., PELTOKETO H. and VAINIO S. (2005). The partial female to male sex reversal in Wnt-4-deficient females involves induced expression of testosterone biosynthetic genes and testosterone production, and depends on androgen action. Endocrinology 146: 4016-4023.
58. HERNANDEZ GIFFORD, J.A., HUNZICKER-DUNN M.E. and NILSON J.H. (2009). Conditional deletion of b-catenin mediated by Amhr2cre in mice causes female infertility. Biol Reprod DOI:10.1095/biolreprod.108.072280.
59. HEWITT, S.C. and KORACH K.S. (2002). Estrogen receptors: structure, mechanisms and function. Rev Endocr Metab Disord 3: 193-200.
60. HOLLIDAY, R. (1990). DNA methylation and epigenetic inheritance. Philos Trans R Soc Lond B Biol Sci 326: 329-338.
61. HOMBRIA, J.C. and LOVEGROVE B. (2003). Beyond homeosis-HOX function in morphogenesis and organogenesis. Differentiation 71: 461-476.
62. HONMA, S., SUZUKI A., BUCHANAN D.L., KATSU Y., WATANABE H. and IGUCHI T. (2002). Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 16: 117-122.
63. HORIKAWA, Y., IWASAKI N., HARA M., FURUTA H., HINOKIO Y., COCKBURN B.N., LINDNER T., YAMAGATA K., OGATA M., TOMONAGA O., KUROKI H., KASAHARA T., IWAMOTO Y. and BELL G.I. (1997). Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet 17: 384-385.
64. HOSSAIN, A. and SAUNDERS G.F. (2003). Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor. J Biol Chem 278: 26511-26516.
65. HUANG, W.W., YIN Y., BI Q., CHIANG T.C., GARNER N., VUORISTO J., MCLACHLAN J.A. and MA L. (2005). Developmental diethylstilbestrol exposure alters genetic pathways of uterine cytodifferentiation. Mol Endocrinol 19: 669-682.
66. IIZUKA-KOGO, A., ISHIDAO T., AKIYAMA T. and SENDA T. (2007). Abnormal development of urogenital organs in Dlgh1-deficient mice. Development 134: 1799-1807.
67. INCE, T.A., CVIKO A.P., QUADE B.J., YANG A., MCKEON F.D., MUTTER G.L. and CRUM C.P. (2002). p63 Coordinates anogenital modeling and epithelial cell differentiation in the developing female urogenital tract. Am J Pathol 161: 1111-1117.
68. ITOH, T., IKEDA T., GOMI H., NAKAO S., SUZUKI T. and ITOHARA S. (1997). Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem. 272: 22389-22392.
69. JACOB, M., KONRAD K. and JACOB H.J. (1999). Early development of the mullerian duct in avian embryos with reference to the human. An ultrastructural and immunohistochemical study. Cells Tissues Organs 164: 63-81.
70. JAMIN, S.P., ARANGO N.A., MISHINA Y., HANKS M.C. and BEHRINGER R.R. (2002). Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet 32: 408-410.
71. JAMIN, S.P., ARANGO N.A., MISHINA Y., HANKS M.C. and BEHRINGER R.R. (2003). Genetic studies of the AMH/MIS signaling pathway for Mullerian duct regression. Mol Cell Endocrinol 211: 15-19.
72. JEFFERSON, W.N., COUSE J.F., PADILLA-BANKS E., KORACH K.S. and NEWBOLD R.R. (2002). Neonatal exposure to genistein induces estrogen receptor (ER)alpha expression and multioocyte follicles in the maturing mouse ovary: evidence for ERbeta-mediated and nonestrogenic actions. Biol Reprod 67: 1285-1296.
73. JEFFERSON, W.N., PADILLA-BANKS E. and NEWBOLD R.R. (2007). Disruption of the female reproductive system by the phytoestrogen genistein. Reprod Toxicol 23: 308-316.
74. JOSSO, N., CATE R.L., PICARD J.Y., VIGIER B., DI CLEMENTE N., WILSON C., IMBEAUD S., PEPINSKY R.B., GUERRIER D., BOUSSIN L. and et al. (1993). Anti-mullerian hormone: the Jost factor. Recent Prog Horm Res 48: 1-59.
75. JOST, A. (1953). Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog Horm Res 8: 379-418.
76. KAUFMAN, R.H., ADAM E., HATCH E.E., NOLLER K., HERBST A.L., PALMER J.R. and HOOVER R.N. (2000). Continued follow-up of pregnancy outcomes in diethylstilbestrol-exposed offspring. Obstet Gynecol 96: 483-489.
77. KIM, Y., KOBAYASHI A., SEKIDO R., DINAPOLI L., BRENNAN J., CHABOISSIER M.C., POULAT F., BEHRINGER R.R., LOVELL-BADGE R. and CAPEL B. (2006). Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4: e187.
78. KIM, H., HAYAHI S., CHAMBON P., WATANABE H., IGUCHI T. and SATO, T. (2009). Effects of diethystilbestrol on ovarian follicle development in neaonatal mice. Reprod. Toxicol. 27: 55-62.
79. KITAJEWSKI, J. and SASSOON D. (2000). The emergence of molecular gynecology: homeobox and Wnt genes in the female reproductive tract. Bioessays. 22: 902-910.
80. KLATTIG, J., SIERIG R., KRUSPE D., BESENBECK B. and ENGLERT C. (2007). Wilms' tumor protein Wt1 is an activator of the anti-Mullerian hormone receptor gene Amhr2. Mol Cell Biol 27: 4355-4364.
81. KOBAYASHI, A. and BEHRINGER R.R. (2003). Developmental genetics of the female reproductive tract in mammals. Nat Rev Genet 4: 969-980.
82. KOBAYASHI, A., KWAN K.M., CARROLL T.J., MCMAHON A.P., MENDELSOHN C.L. and BEHRINGER R.R. (2005). Distinct and sequential tissue-specific activities of the LIM-class homeobox gene Lim1 for tubular morphogenesis during kidney development. Development 132: 2809-2823.
83. KOBAYASHI, A., SHAWLOT W., KANIA A. and BEHRINGER R.R. (2004). Requirement of Lim1 for female reproductive tract development. Development 131: 539-549.
84. KOLATSI-JOANNOU, M., BINGHAM C., ELLARD S., BULMAN M.P., ALLEN L.I., HATTERSLEY A.T. and WOOLF A.S. (2001). Hepatocyte nuclear factor-1beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol 12: 2175-2180.
85. KOMATSU, M. and FUJITA H. (1978). Electron-microscopic studies on the development and aging of the oviduct epithelium of mice. Anat Embryol (Berl) 152: 243-259.
86. KURITA, T., COOKE P.S. and CUNHA G.R. (2001). Epithelial-stromal tissue interaction in paramesonephric (Mullerian) epithelial differentiation. Dev Biol 240: 194-211.
87. KURITA, T., MILLS A.A. and CUNHA G.R. (2004). Roles of p63 in the diethylstilbestrol-induced cervicovaginal adenosis. Development 131: 1639-1649.
88. LI, S., HANSMAN R., NEWBOLD R., DAVIS B., MCLACHLAN J.A. and BARRETT J.C. (2003). Neonatal diethylstilbestrol exposure induces persistent elevation of c-fos expression and hypomethylation in its exon-4 in mouse uterus. Mol Carcinog 38: 78-84.
89. LI, S., MA L., CHIANG T., BUROW M., NEWBOLD R.R., NEGISHI M., BARRETT J.C. and MCLACHLAN J.A. (2001a). Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure. Mol Carcinog 32: 213-219.
90. LI, S., MA L., CHIANG T., BUROW M., NEWBOLD R.R., NEGISHI M., BARRETT J.C. and MCLACHLAN J.A. (2001b). Promoter CpG methylation of Hox-a10 and Hox-a11 in mouse uterus not altered upon neonatal diethylstilbestrol exposure. Mol Carcinog 32: 213-219.
91. LI, S., WASHBURN K.A., MOORE R., UNO T., TENG C., NEWBOLD R.R., MCLACHLAN J.A. and NEGISHI M. (1997). Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus. Cancer Res 57: 4356-4359.
92. LINDNER, T.H., NJOLSTAD P.R., HORIKAWA Y., BOSTAD L., BELL G.I. and SOVIK O. (1999). A novel syndrome of diabetes mellitus, renal dysfunction and genital malformation associated with a partial deletion of the pseudo-POU domain of hepatocyte nuclear factor-1beta. Hum Mol Genet 8: 2001-2008.
93. LOOSE-MITCHELL, D.S., CHIAPPETTA C. and STANCEL G.M. (1988). Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 2: 946-951.
94. MA, L., BENSON G.V., LIM H., DEY S.K. and MAAS R.L. (1998). Abdominal B (AbdB) Hoxa genes: regulation in adult uterus by estrogen and progesterone and repression in mullerian duct by the synthetic estrogen diethylstilbestrol (DES). Dev Biol 197: 141-154.
95. MARKEY, C.M., COOMBS M.A., SONNENSCHEIN C. and SOTO A.M. (2003). Mammalian development in a changing environment: exposure to endocrine disruptors reveals the developmental plasticity of steroid-hormone target organs. Evol Dev 5: 67-75.
96. MCLACHLAN, J.A., NEWBOLD R.R. and BULLOCK B.C. (1980). Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40: 3988-3999.
97. MENDELSOHN, C., LOHNES D., DECIMO D., LUFKIN T., LEMEUR M., CHAMBON P. and MARK M. (1994). Function of the retinoic acid receptors (RARs) during development (II). Multiple abnormalities at various stages of organogenesis in RAR double mutants. Development 120: 2749-2771.
98. MERICSKAY, M., KITAJEWSKI J. and SASSOON D. (2004). Wnt5a is required for proper epithelial-mesenchymal interactions in the uterus. Development 131: 2061-2072.
99. MILLER, C., DEGENHARDT K. and SASSOON D.A. (1998a). Fetal exposure to DES results in de-regulation of Wnt7a during uterine morphogenesis. Nat Genet 20: 228-230.
100. MILLER, C., PAVLOVA A. and SASSOON D.A. (1998b). Differential expression patterns of Wnt genes in the murine female reproductive tract during development and the estrous cycle. Mech Dev 76: 91-99.
101. MILLER, C. and SASSOON D.A. (1998). Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development 125: 3201-3211.
102. MISHINA, Y., REY R., FINEGOLD M.J., MATZUK M.M., JOSSO N., CATE R.L. and BEHRINGER R.R. (1996). Genetic analysis of the Mullerian-inhibiting substance signal transduction pathway in mammalian sexual differentiation. Genes Dev 10: 2577-2587.
103. MIYAMOTO, N., YOSHIDA M., KURATANI S., MATSUO I. and AIZAWA S. (1997). Defects of urogenital development in mice lacking Emx2. Development 124: 1653-1664.
104. MORCEL, K., CAMBORIEUX L. and GUERRIER D. (2007). Mayer-Rokitansky- Kuster-Hauser (MRKH) syndrome. Orphanet J Rare Dis 2: 13.
105. MORTLOCK, D.P. and INNIS J.W. (1997). Mutation of HOXA13 in hand-footgenital syndrome. Nat Genet 15: 179-80.
106. MURAMATSU, M. and INOUE S. (2000). Estrogen receptors: how do they control reproductive and nonreproductive functions? Biochem Biophys Res Commun. 270: 1-10.
107. NELSON, K.G., SAKAI Y., EITZMAN B., STEED T. and MCLACHLAN J. (1994). Exposure to diethylstilbestrol during a critical developmental period of the mouse reproductive tract leads to persistent induction of two estrogen-regulated genes. Cell Growth Differ 5: 595-606.
108. NEWBOLD, R.R., BANKS E.P., BULLOCK B. and JEFFERSON W.N. (2001). Uterine adenocarcinoma in mice treated neonatally with genistein. Cancer Res 61: 4325-4328.
109. NEWBOLD, R.R., BULLOCK B.C. and MCLACHLAN J.A. (1990). Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50: 7677-7681.
110. NEWBOLD, R.R., HANSON R.B. and JEFFERSON W.N. (1997). Ontogeny of lactoferrin in the developing mouse uterus: a marker of early hormone response. Biol Reprod 56: 1147-1157.
111. NEWBOLD, R.R., HANSON R.B., JEFFERSON W.N., BULLOCK B.C., HASEMAN J. and MCLACHLAN J.A. (1998). Increased tumors but uncompromised fertility in the female descendants of mice exposed developmentally to diethylstilbestrol. Carcinogenesis 19: 1655-1663.
112. NEWBOLD, R.R., JEFFERSON W.N. and PADILLA-BANKS E. (2007a). Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24: 253-258.
113. NEWBOLD, R.R., PADILLA-BANKS E., SNYDER R.J. and JEFFERSON W.N. (2007b). Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 51: 912-917.
114. NEWBOLD, R.R., PADILLA-BANKS E., SNYDER R.J., PHILLIPS T.M. and JEFFERSON W.N. (2007c). Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23: 290-296.
115. OPPELT, P., S P.R., KELLERMANN A., BRUCKER S., G A.H., K S.L., P L.S., STRICK R., WALLWIENER D. and M W.B. (2005a). Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod. 21: 792-797.
116. OPPELT, P., STRISSEL P.L., KELLERMANN A., SEEBER S., HUMENY A., BECKMANN M.W. and STRICK R. (2005b). DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndrome. Hum Reprod 20: 149-157.
117. ORVIS, G.D. and BEHRINGER R.R. (2007). Cellular mechanisms of Mullerian duct formation in the mouse. Dev Biol 306: 493-504.
118. PARR, B.A., AVERY E.J., CYGAN J.A. and MCMAHON A.P. (1998). The classical mouse mutant postaxial hemimelia results from a mutation in the Wnt 7a gene. Dev Biol 202: 228-234.
119. PARR, B.A. and MCMAHON A.P. (1998). Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature 395: 707-710.
120. POIRIER, L.A. and VLASOVA T.I. (2002). The prospective role of abnormal methyl metabolism in cadmium toxicity. Environ Health Perspect 110 Suppl 5: 793-795.
121. REBER, M. and CEREGHINI S. (2001). Variant hepatocyte nuclear factor 1 expression in the mouse genital tract. Mech Dev 100: 75-78.
122. ROBERT, B. and LALLEMAND Y. (2006). Anteroposterior patterning in the limb and digit specification: contribution of mouse genetics. Dev Dyn. 235: 2337-2352.
123. ROBERTS, L.M., VISSER J.A. and INGRAHAM H.A. (2002). Involvement of a matrix metalloproteinase in MIS-induced cell death during urogenital development. Development 129: 1487-1496.
124. SAINIO, K., HELLSTEDT P., KREIDBERG J.A., SAXEN L. and SARIOLA H. (1997). Differential regulation of two sets of mesonephric tubules by WT-1. Development 124: 1293-1299.
125. SAINIO, K. and RAATIKAINEN-AHOKAS A. (1999). Mesonephric kidney-a stem cell factory? Int J Dev Biol 43: 435-439.
126. SALNIKOW, K. and COSTA M. (2000). Epigenetic mechanisms of nickel carcinogenesis. J Environ Pathol Toxicol Oncol 19: 307-318.
127. SATO, K., FUKATA H., KOGO Y., OHGANE J., SHIOTA K. and MORI, C. (2009). Neonatal exposure to diethylstilbestrol alters expression of DNA methyltransferases and methylation of genomic DNA in mouse uterus. Endocrinol. J. 56: 131-139.
128. SAXEN, L. and SARIOLA H. (1987). Early organogenesis of the kidney. Pediatr Nephrol 1: 385-392.
129. TABB, M.M. and BLUMBERG B. (2006). New modes of action for endocrinedisrupting chemicals. Mol Endocrinol 20: 475-482.
130. TANG, W.Y., NEWBOLD R., MARDILOVICH K., JEFFERSON W., CHENG R.Y.S., MEDVEDOVIC M. and HO, S.M. (2008). Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of Nsbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149: 5922-5931.
131. TAYLOR, H.S., VANDEN HEUVEL G.B. and IGARASHI P. (1997). A conserved Hox axis in the mouse and human female reproductive system: late establishment and persistent adult expression of the Hoxa cluster genes. Biol Reprod 57: 1338-1345.
132. TONG, G.X., CHIRIBOGA L., HAMELE-BENA D. and BORCZUK A.C. (2007) Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin? Mod Pathol 20: 856-863.
133. TORRES, M., GOMEZ-PARDO E., DRESSLER G.R. and GRUSS P. (1995). Pax-2 controls multiple steps of urogenital development. Development 121: 4057-4065.
134. VAINIO, S., HEIKKILA M., KISPERT A., CHIN N. and MCMAHON A.P. (1999). Female development in mammals is regulated by Wnt-4 signalling. Nature 397: 405-409.
135. WALKER, B.E. and HAVEN M.I. (1997). Intensity of multigenerational carcinogenesis from diethylstilbestrol in mice. Carcinogenesis 18: 791-793.
136. WAROT, X., FROMENTAL-RAMAIN C., FRAULOB V., CHAMBON P. and DOLLE P. (1997). Gene dosage-dependent effects of the Hoxa-13 and Hoxd-13 mutations on morphogenesis of the terminal parts of the digestive and urogenital tracts. Development. 124: 4781-4791.
137. WATERLAND, R.A., LIN J.R., SMITH C.A. and JIRTLE R.L. (2006). Post-weaning diet affects genomic imprinting at the insulin-like growth factor 2 (Igf2) locus. Hum Mol Genet 15: 705-716.
138. WOLFF, G.L., KODELL R.L., MOORE S.R. and COONEY C.A. (1998). Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice. FASEB J 12: 949-957.
139. WROBEL, K.H., HEES I., SCHIMMEL M. and STAUBER E. (2002). The genus Acipenser as a model system for vertebrate urogenital development: nephrostomial tubules and their significance for the origin of the gonad. Anat Embryol (Berl) 205: 67-80.
140. YIN, Y., LIN C. and MA L. (2006). MSX2 promotes vaginal epithelial differentiation and wolffian duct regression and dampens the vaginal response to diethylstilbestrol. Mol Endocrinol 20: 1535-1546.
141. ZHAN, Y., FUJINO A., MACLAUGHLIN D.T., MANGANARO T.F., SZOTEK P.P., ARANGO N.A., TEIXEIRA J. and DONAHOE P.K. (2006). Mullerian inhibiting substance regulates its receptor/SMAD signaling and causes mesenchymal transition of the coelomic epithelial cells early in Mullerian duct regression. Development 133: 2359-2369.
142. ZHAO, Y. and POTTER S.S. (2001). Functional specificity of the Hoxa13 homeobox. Development 128: 3197-3207.